Experience

Davis Polk is advising Advanced Accelerator Applications S.A. on its $3.9 billion acquisition by Novartis. Entry into the definitive agreement has been approved by the board of…

Davis Polk advised GeoPark Limited in connection with the offering of $425 million aggregate principal amount of its 6.500% senior secured notes due 2024. The notes were sold in an…

Davis Polk advised Banco de Bogotá S.A. in connection with its global offering of $600 million aggregate principal amount of its 4.375% senior notes due 2027, pursuant to Rule 144A and…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering of 11,000,000 shares of common stock of XPO Logistics, Inc. and advised the…

Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of $200 million aggregate principal amount of Callon Petroleum Company’s…

Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 7,000,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised Murphy USA Inc. in connection with an SEC-registered offering of $300 million aggregate principal amount of 5.625% senior notes due 2027. The notes were issued by Murphy…

Davis Polk advised the underwriters in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of Evolent’s existing stockholders…

Davis Polk advised Heineken N.V. on its offering of $1.1 billion aggregate principal amount of its 3.50% senior notes due 2028 and $650 million aggregate principal amount of its 4.35%…